0001382963-18-000009.txt : 20180125
0001382963-18-000009.hdr.sgml : 20180125
20180125210010
ACCESSION NUMBER: 0001382963-18-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180123
FILED AS OF DATE: 20180125
DATE AS OF CHANGE: 20180125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ritter Ira E.
CENTRAL INDEX KEY: 0001631674
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 18549713
MAIL ADDRESS:
STREET 1: C/O RITTER PHARMACEUTICALS INC.
STREET 2: 1801 CENTURY PARK EAST, SUITE 1820
CITY: LOS ANGELES
STATE: CA
ZIP: 90096
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 310-203-1000
MAIL ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-01-23
0001460702
RITTER PHARMACEUTICALS INC
RTTR
0001631674
Ritter Ira E.
RITTER PHARMACEUTICALS, INC.
1880 CENTURY PARK EAST, SUITE 1000
LOS ANGELES
CA
90067
1
1
0
0
Exec. Chairman, CSO
Non-Qualified Stock Option (Right to Buy)
.34
2018-01-23
4
A
0
495065
0
A
2028-01-23
Common Stock
495065
495065
D
The option vests in forty-eight (48) equal monthly installments beginning on February 23, 2018 with the balance vesting on the 23rd day of each calendar month thereafter until vested in full.
/s/Andrew J. Ritter, attorney-in-fact
2018-01-25